SCI Abstract

search
+
Venetoclax-based combination regimens for therapy-related myeloid neoplasms
Venetoclax-based combination regimens for therapy-related myeloid neoplasms
Therapy-related myeloid neoplasms (t-MN) are an aggressive and heterogeneous group of myeloid disorders with no establishe...
Safety and effectiveness of lisocabtagene maraleucel following PD-1 blockade in relapsed or refractory PMBCL
Safety and effectiveness of lisocabtagene maraleucel following PD-1 blockade in relapsed or refractory PMBCL
Primary mediastinal B-cell lymphoma (PMBCL) is a distinct subtype of large B-cell lymphoma characterized by 9p24.1 copy-nu...
A phase I/II study of tagraxofusp in Japanese patients with blastic plasmacytoid dendritic cell neoplasm
A phase I/II study of tagraxofusp in Japanese patients with blastic plasmacytoid dendritic cell neoplasm
Tagraxofusp (TAG), a first-in-class CD123-targeted therapy, is a recombinant fusion protein of human interleukin-3 conjuga...
Prognostic factors influencing outcomes of allogeneic HCT for AML with monosomal karyotype
Prognostic factors influencing outcomes of allogeneic HCT for AML with monosomal karyotype
Monosomal karyotype (MK) comprises chromosomal abnormalities defined as either one single autosomal monosomy with structur...
Cutaneous T-cell lymphoma in Kuwait: a retrospective analysis of treatment modalities and prognostic factors
Cutaneous T-cell lymphoma in Kuwait: a retrospective analysis of treatment modalities and prognostic factors
Cutaneous T-cell lymphoma (CTCL) is a rare malignancy with limited data available from the Middle East. This study evaluat...
Belantamab mafodotin, pomalidomide, and dexamethasone in Japanese patients with RRMM in the phase 3 DREAMM-8 trial
Belantamab mafodotin, pomalidomide, and dexamethasone in Japanese patients with RRMM in the phase 3 DREAMM-8 trial
The phase 3 DREAMM-8 (NCT04484623) trial assessed belantamab mafodotin + pomalidomide + dexamethas...
Viral-driven oncogenesis in T/NK-cell lymphomas: parallels and divergences between HTLV-1 and EBV
Viral-driven oncogenesis in T/NK-cell lymphomas: parallels and divergences between HTLV-1 and EBV
Viruses induce approximately 12% of human cancers, including lymphomas. In the case of T/NK cell neoplasms, human T-cell l...
Correction: Recent advances of cell therapies for AML/MDS: exploring the therapeutic potential of innate immune cells in AML/MDS
Correction: Recent advances of cell therapies for AML/MDS: exploring the therapeutic potential of innate immune cells in AML/MDS
Cite this articleChang, YH., Goyama, S. Correction: Recent advances of cell therapies for AML/MDS: exploring the therapeut...
Three-year follow-up of epcoritamab therapy in Japanese patients with relapsed/refractory follicular lymphoma in EPCORE NHL-3
Three-year follow-up of epcoritamab therapy in Japanese patients with relapsed/refractory follicular lymphoma in EPCORE NHL-3
The CD3xCD20 bispecific antibody epcoritamab demonstrated deep, durable responses with manageable safety in relapsed/refra...
Ruxolitinib in relapsed/refractory TAFRO syndrome: a report of two cases, including one positive for Epstein–Barr virus, and a literature review
Ruxolitinib in relapsed/refractory TAFRO syndrome: a report of two cases, including one positive for Epstein–Barr virus, and a literature review
TAFRO syndrome is a rare systemic inflammatory disorder characterized by thrombocytopenia, anasarca, fever, reticulin fibr...
Association of busulfan area under the curve with the development of neurotoxicity in children and adolescents receiving busulfan-containing conditioning regimens for stem cell transplantation
Association of busulfan area under the curve with the development of neurotoxicity in children and adolescents receiving busulfan-containing conditioning regimens for stem cell transplantation
Although several studies suggest that higher busulfan exposure is associated with neurotoxicity, research on the relevance...
Clinical correlation between plasma biomarker levels and post-transplant complications of allogeneic hematopoietic stem cell transplantation in children
Clinical correlation between plasma biomarker levels and post-transplant complications of allogeneic hematopoietic stem cell transplantation in children
This study investigated the correlation between plasma biomarker levels and post-transplant complications of allo-HSCT in ...
Persistent low-level EBV-DNA detection in non-plasma compartments during convalescence after pediatric EBV-HLH
Persistent low-level EBV-DNA detection in non-plasma compartments during convalescence after pediatric EBV-HLH
The datasets generated and/or analyzed during the current study are not publicly available due t...
Salvage radiotherapy in refractory adult Hodgkin and non-Hodgkin lymphoma
Salvage radiotherapy in refractory adult Hodgkin and non-Hodgkin lymphoma
Although Hodgkin and non-Hodgkin lymphoma are chemosensitive, 10–15% of patients develop refractory disease. With th...
Novel agents and therapeutic advances in T cell lymphoma
Novel agents and therapeutic advances in T cell lymphoma
Peripheral T cell lymphomas (PTCLs) are a heterogeneous group of aggressive lymphomas with generally poor outcomes. CHOP o...
Impact of diagnosis-to-treatment interval in relapsed or refractory diffuse large B-cell lymphoma
Impact of diagnosis-to-treatment interval in relapsed or refractory diffuse large B-cell lymphoma
The diagnosis-to-treatment interval (DTI) has been identified as a prognostic factor in newly diagnosed diffuse large B-ce...
Micafungin-induced hemolytic anemia: a case report and investigation of anti-micafungin antibody prevalence
Micafungin-induced hemolytic anemia: a case report and investigation of anti-micafungin antibody prevalence
Micafungin and other echinocandins are commonly used for the prophylaxis and empirical treatment of invasive fungal infect...
Ropeginterferon-α2b discontinuation after long-term exposure: four cases from a single institution
Ropeginterferon-α2b discontinuation after long-term exposure: four cases from a single institution
Polycythemia vera (PV) is a Philadelphia chromosome-negative myeloproliferative neoplasm driven by JAK2 mutations, leading...
Comparison of clinical outcomes between preemptive and maintenance therapy after allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia
Comparison of clinical outcomes between preemptive and maintenance therapy after allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia
This study aimed to compare the efficacy and safety of preemptive and maintenance therapies as post-transplant therapy for...
Early withdrawal immunosuppression improved mixed chimerism in stem cell transplantation for pediatric aplastic anemia
Early withdrawal immunosuppression improved mixed chimerism in stem cell transplantation for pediatric aplastic anemia
Mixed chimerism occurs frequently with the risk of graft rejection for aplastic anemia patients undergoing matched sibling...
Transient bilateral ureteral stones in a patient with BK viral infection after hematopoietic stem cell transplantation
Transient bilateral ureteral stones in a patient with BK viral infection after hematopoietic stem cell transplantation
Cite this articleIkeda, T., Sugiyama, T., Tokunaga, M. et al. Transient bilateral ureteral stones in a patient with BK vir...
Asciminib in patients with newly diagnosed chronic myeloid leukemia: results from the Japanese subgroup of ASC4FIRST
Asciminib in patients with newly diagnosed chronic myeloid leukemia: results from the Japanese subgroup of ASC4FIRST
The phase III ASC4FIRST study (NCT04971226) demonstrated superior efficacy and favorable safety and tolerability for ascim...
A pluripotent stem cell model of Emberger syndrome reveals reduced lymphatic endothelial differentiation
A pluripotent stem cell model of Emberger syndrome reveals reduced lymphatic endothelial differentiation
Emberger syndrome (ES), an autosomal dominant disorder characterized by congenital deafness, primary lymphedema, and predi...
JSH practical guidelines for hematological malignancies, 2023: II. Lymphoma5. Diffuse large B-cell lymphoma, not otherwise specified (DLBCL, NOS)
JSH practical guidelines for hematological malignancies, 2023: II. Lymphoma5. Diffuse large B-cell lymphoma, not otherwise specified (DLBCL, NOS)
Swerdlow SH, et al editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC; 2017. ...
JSH practical guidelines for hematological malignancies, 2023: II. lymphoma 9—adult T-cell leukemia–lymphoma (ATL)
JSH practical guidelines for hematological malignancies, 2023: II. lymphoma 9—adult T-cell leukemia–lymphoma (ATL)
1)Utsunomiya A, et al. Improved outcome of adult T-cell leukemia/lymphoma with allogeneic hematopoietic stem cell transpla...
Transient lupus anticoagulant induced by adenovirus cystitis in a bone marrow transplant recipient
Transient lupus anticoagulant induced by adenovirus cystitis in a bone marrow transplant recipient
Adenovirus-associated hemorrhagic cystitis (AdV-HC) is a serious complication of hematopoietic stem cell transplantation (...
Utility of tolvaptan sodium phosphate for refractory fluid retention in post-transplant sinusoidal obstruction syndrome
Utility of tolvaptan sodium phosphate for refractory fluid retention in post-transplant sinusoidal obstruction syndrome
Sinusoidal obstruction syndrome (SOS) is a life-threatening complication of hematopoietic stem cell transplantation (HSCT)...
Therapeutic impact of mesenchymal stem cells on idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation
Therapeutic impact of mesenchymal stem cells on idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation
Mesenchymal stem cells (MSCs) effectively treat steroid-refractory acute graft-versus-host disease (aGVHD). However, their...
JSH practical guidelines for hematological malignancies, 2023: II. Lymphoma 7. Peripheral T-cell lymphoma (PTCL)
JSH practical guidelines for hematological malignancies, 2023: II. Lymphoma 7. Peripheral T-cell lymphoma (PTCL)
Conflict of interest DM has received per diem, including speaking f...
JSH practical guidelines for hematological malignancies, 2023: II. Lymphoma 8. Extranodal NK/T-cell lymphoma, nasal type (ENKL)
JSH practical guidelines for hematological malignancies, 2023: II. Lymphoma 8. Extranodal NK/T-cell lymphoma, nasal type (ENKL)
Conflict of interest DM has received per diem, including speaking f...
Load More
format_indent_increase